Skip to main content
. 2023 Mar 14;25(10):1871–1882. doi: 10.1093/neuonc/noad055

Table 2.

Summary of Accuracy for Key BIOMECA Tests Under Evaluation Stratified by Center and Test Type. BIOMECA Tests With Equivocal or No Result Removed From Calculation. For Gain of Chromosome 1q Only Partial Chromosomal Gains Included in Analysis—Cases With Whole Chromosome Excluded as Known to Only be Detectable With MIP. Test Accuracy Calculated by True Positives and True Negatives Divided by All Test Results. Confidence Intervals Calculated Via the Exact Binomial Approach.

Parameter Criterion Standard (CS) BIOMECA Test Center Positive CS and BIOMECA test (N) Positive CS/ Negative BIOMECA test (N) Sensitivity (95% CI) Negative CS and BIOMECA test (N) Negative CS and Positive BIOMECA test (N) Specificity (95% CI) No result (BIOMECA test) (N) BIOMECA Accuracy (%)
PFA Diagnosis in confirmed PF ependymoma MA H3K27me3 IHC Austria 94 1 99.0 (94.3–100) 10 0 100
(69.2–100)
1 99.1
Germany 94 0 100 (96.2–100) 8 0 100
(63.2–100)
4 100
UK 94 1 99.0 (94.3–100) 9 1 90.0 (55.5–99.8) 1 98.1
TNC IHC Austria 94 2 97.9 (92.7–99.8) 6 4 60 (26.2–87.9) 0 94.3
France 88 8 91.7 (84.2–96.3) 7 3 70 (34.8–93.3) 0 89.6
Chromosome 1q Gain across all molecular diagnoses MA 1q FISH UK 9 6 60.0 (32.3–83.7 93 4 95.9 (89.8–98.9) 17 91.1
France 15 3 83.3 (58.6–96.4) 67 12 84.8 (75.0–91.9) 32 84.5
MLPA UK 18 1 94.7 (74–99.9) 109 0 100 (96.7–100) 1 99.2
MIP Germany 18 1 94.7
(74–99.9)
110 0 100 (96.7–100) 0 99.2
Diagnosis of ST EPN with gene fusions with RELA MA plus targeted profiling for RELA p65 IHC Germany 18 0 100 (81.5–100) 6 0 100 (54.1–100) 1 100
France 16 2 88.9 (65.6–98.6) 6 1 85.7 (42.1–99.6) 0 88

CS, Criterion Standard; MA, DNA Methylation Array; PF, Posterior Fossa; ST, Supratentorial; IHC, Immunohistochemistry; FISH, Fluorescent In Situ Hybridization; CI, Confidence Interval.